A detailed history of Nalls Sherbakoff Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 1,172 shares of PFE stock, worth $34,867. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,172
Previous 1,222 4.09%
Holding current value
$34,867
Previous $40.5 Million 16.76%
% of portfolio
0.03%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 09, 2024

SELL
$26.13 - $33.94 $1,306 - $1,697
-50 Reduced 4.09%
1,172 $33.7 Million
Q3 2023

Oct 17, 2023

SELL
$32.09 - $37.51 $32 - $37
-1 Reduced 0.08%
1,222 $40.5 Million
Q1 2023

Oct 17, 2023

SELL
$39.39 - $51.28 $29,818 - $38,818
-757 Reduced 38.23%
1,223 $49.4 Million
Q4 2018

Feb 15, 2019

BUY
$38.47 - $43.86 $68,553 - $78,158
1,782 Added 900.0%
1,980 $86,000
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $7,617 - $8,684
198 New
198 $85,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nalls Sherbakoff Group, LLC Portfolio

Follow Nalls Sherbakoff Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nalls Sherbakoff Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nalls Sherbakoff Group, LLC with notifications on news.